Reaction
Stoma Complication reporting signals
As of the last recalculation, Stoma Complication appears in 1,007 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 943.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 382 | 943.5 | 971.2 |
| Carbidopa And Levodopa | 107 | 52.0 | 52.2 |
| Diphenoxylate Hydrochloride And Atropine Sulfate | 33 | 51.4 | 51.6 |
| Amantadine | 25 | 34.2 | 34.3 |
| Ropinirole | 19 | 26.1 | 26.1 |
| Cholestyramine | 15 | 26.0 | 26.0 |
| Loperamide Hydrochloride And Dimethicone | 31 | 20.6 | 20.6 |
| Rivastigmine | 17 | 19.0 | 19.0 |
| Terazosin Hydrochloride | 8 | 18.7 | 18.7 |
| Octreotide Acetate | 26 | 18.0 | 18.0 |
| Pramipexole | 13 | 17.8 | 17.8 |
| Loperamide Hydrochloride | 35 | 16.7 | 16.7 |
| Rotigotine | 10 | 14.4 | 14.4 |
| Loperamide Hydrochloride Oral | 7 | 14.3 | 14.3 |
| Ursosiol | 13 | 14.0 | 14.0 |
| Levodopa | 8 | 13.8 | 13.8 |
| Infliximab-Dyyb | 19 | 13.7 | 13.7 |
| Rasagiline Mesylate | 7 | 13.1 | 13.1 |
| Methadone Hydrochloride | 6 | 11.5 | 11.5 |
| Panitumumab | 7 | 9.3 | 9.3 |
| Risankizumab-Rzaa | 25 | 6.5 | 6.5 |